6 x
MG:
MAGNESIUM ION(Non-functional Binders)(Non-covalent)
MG.2:
1
residues within 4Å:
Chain A:
K.164
No protein-ligand interaction detected (PLIP)
MG.3:
1
residues within 4Å:
Chain A:
E.7
3 PLIP interactions:
1 interactions with chain A,
2 Ligand-Water interactions
Metal complexes:
A:E.7,
H2O.2,
H2O.6
MG.4:
4
residues within 4Å:
Chain A:
R.90,
E.91,
E.94,
Q.98
4 PLIP interactions:
1 interactions with chain A,
3 Ligand-Water interactions
Metal complexes:
A:E.94,
H2O.4,
H2O.8,
H2O.9
MG.7:
1
residues within 4Å:
Chain B:
K.164
No protein-ligand interaction detected (PLIP)
MG.8:
1
residues within 4Å:
Chain B:
E.7
3 PLIP interactions:
1 interactions with chain B,
2 Ligand-Water interactions
Metal complexes:
B:E.7,
H2O.12,
H2O.17
MG.9:
4
residues within 4Å:
Chain B:
R.90,
E.91,
E.94,
Q.98
4 PLIP interactions:
1 interactions with chain B,
3 Ligand-Water interactions
Metal complexes:
B:E.94,
H2O.14,
H2O.18,
H2O.20
2 x
SKR:
~{N}-[(2~{S})-2-[(1~{E},3~{R},4~{S},8~{R},9~{R},10~{R},11~{S},14~{S})-14-(methoxymethyl)-3,10-dimethyl-4,8,9-tris(oxidanyl)-6-tricyclo[9.3.0.0^{3,7}]tetradeca-1,6-dienyl]propyl]ethanamide
Visser, E.J. et al., Stabilization of the Estrogen receptor alpha - 14-3-3 interaction as a potential intervention strategy for endocrine resistance in breast cancer. To Be Published
